BMYBristol-Myers Squibb Company
Healthcare · Drug Manufacturers - GeneralNYSEStockMkt cap $133B
Disclosed trades
105
0 in 30d · 0 in 90d
Politicians
28
Last trade Jun 16, 2026
Buys
46
$722.5K at range midpoints
Sells
59
$1.2M at range midpoints
Closing price · 365 days
Nov 6, 2025 – Nov 5, 2026
Monthly buys vs sells · 24 months
Counts of disclosed transactions
- Buys
- Sells (incl. partial)
Politicians who traded it
12 hold it now Estimated
| Politician | Seat | Trades | Buys | Sells | Bought (mid) | Sold (mid) | Last trade | Est. position Estimated |
|---|---|---|---|---|---|---|---|---|
| DRo Khanna | House · CA-17 | 30 | 17 | 13 | $307.5K | $226.5K | Jun 16, 2026 | $115.1K |
| DThomas R. Suozzi | House · NY-03 | 14 | 3 | 11 | $115.5K | $161.5K | Jun 7, 2021 | $39.4K |
| RTommy Tuberville | Senate · AL | 8 | 3 | 5 | $48.5K | $40K | Apr 15, 2025 | $9.9K |
| RDiana Harshbarger | House · TN-01 | 7 | 3 | 4 | $24K | $32K | Jan 25, 2023 | $6.9K |
| DGilbert Ray Cisneros, Jr. | House · CA-31 | 5 | 3 | 2 | $24K | $16K | Dec 19, 2025 | $19.6K |
| DJulie Johnson | House · TX-32 | 5 | 1 | 4 | $8K | $32K | Dec 18, 2025 | — |
| DDaniel S. Goldman | House · NY-10 | 4 | 1 | 3 | $75K | $215.5K | Jul 12, 2023 | $34.4K |
| DKatherine M. Clark | House · MA-05 | 4 | 2 | 2 | $16K | $16K | Oct 22, 2020 | $1.6K |
| RDan Sullivan | Senate · AK | 3 | 0 | 3 | $0 | $24K | Aug 22, 2023 | — |
| RJohn H. Rutherford | House · FL-05 | 3 | 2 | 1 | $16K | $8K | Mar 16, 2022 | $10K |
| DMikie Sherrill | House · NJ-11 | 3 | 1 | 2 | $8K | $16K | Feb 20, 2020 | — |
| DGreg Stanton | House · AZ-04 | 2 | 1 | 1 | $8K | $8K | Oct 24, 2023 | — |
| DJohn A. Yarmuth | House · KY-03 | 2 | 2 | 0 | $16K | $0 | Sep 23, 2021 | $16.7K |
| RJohn James | House · MI-10 | 2 | 1 | 1 | $8K | $8K | Jan 18, 2024 | — |
| RJulia Letlow | House · LA-05 | 2 | 1 | 1 | $8K | $8K | Apr 28, 2025 | — |
| DKurt Schrader | House · OR-05 | 2 | 0 | 2 | $0 | $16K | Nov 8, 2022 | — |
| DRick Larsen | House · WA-02 | 2 | 1 | 1 | $8K | $8K | Jan 9, 2024 | — |
| RShelley Moore Capito | Senate · WV | 2 | 0 | 2 | $0 | $16K | May 10, 2023 | — |
| RVan Taylor | House · TX-03 | 2 | 0 | 2 | $0 | $350K | Nov 28, 2022 | — |
| RVirginia Foxx | House · NC-05 | 2 | 1 | 1 | $8K | $8K | Jun 24, 2025 | — |
| RAlan Armstrong | Senate · OK | 1 | 1 | 0 | $8K | $0 | Mar 27, 2026 | $8.6K |
| RCarol D. Miller | House · WV-01 | 1 | 0 | 1 | $0 | $32.5K | Nov 10, 2021 | — |
| DGreg Landsman | House · OH-01 | 1 | 0 | 1 | $0 | $8K | Mar 27, 2025 | — |
| RJefferson Shreve | House · IN-06 | 1 | 0 | 1 | $0 | $32.5K | May 12, 2025 | — |
| DKathy E. Manning | House · NC-06 | 1 | 1 | 0 | $8K | $0 | Jul 15, 2022 | $6.7K |
| DKim Schrier | House · WA-08 | 1 | 0 | 1 | $0 | $8K | Oct 28, 2021 | — |
| RMike Kelly | House · PA-16 | 1 | 0 | 1 | $0 | $32.5K | May 7, 2026 | — |
| DVal T. Hoyle | House · OR-04 | 1 | 1 | 0 | $8K | $0 | Oct 29, 2024 | $9.6K |
Option trades on BMY
| Member | Trade | Type | Strike | Expiry | Contracts | Amount (disclosed) | Traded | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| RTommy Tuberville | Buy | put | $50 | Jun 21, 2024 | — | $1,001 - $15,000 | Apr 3, 2024 | expired | Filing |
| RTommy Tuberville | Sell | put | $50 | Jun 21, 2024 | — | $1,001 - $15,000 | Nov 16, 2023 | — | Filing |
Recent trades
| Politician | Ticker | Asset | Type | Owner | Amount | vs S&P Estimated | Traded | Filed | Source |
|---|---|---|---|---|---|---|---|---|---|
| RTommy Tuberville | BMY | Bristol-Myers Squibb Company | SellRestated | Self | $1,001 - $15,000 | -4.0% | Apr 15, 2025 | Aug 5, 2026477d | Filing |
| RAlan Armstrong | BMY | Bristol-Myers Squibb Company Common Stock | Buy | Self | $1,001 - $15,000 | +5.7% | Mar 27, 2026 | Jul 21, 2026116d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Sell | Spouse | $1,001 - $15,000 | -13.8% | Jun 16, 2026 | Jul 6, 202620d | FilingOCR |
| RMike Kelly | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Spouse | $15,001 - $50,000 | -11.6% | May 7, 2026 | Jun 11, 202635d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Spouse | $1,001 - $15,000 | -3.9% | Feb 5, 2026 | Mar 9, 202632d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | BuyReview | Unknown | $1,001 - $15,000 | -4.3% | Jan 23, 2026 | Feb 6, 202614d | FilingOCR |
| DJulie Johnson | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Joint | $1,001 - $15,000 | -5.6% | Dec 18, 2025 | Jan 15, 202628d | Filing |
| RJulia Letlow | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Self | $1,001 - $15,000 | -7.2% | Apr 28, 2025 | Jan 13, 2026260d | Filing |
| RJulia Letlow | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Buy | Self | $1,001 - $15,000 | +7.2% | Oct 23, 2024 | Jan 13, 2026447d | Filing |
| DGilbert Ray Cisneros, Jr. | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Buy | Self | $1,001 - $15,000 | +7.8% | Dec 19, 2025 | Jan 12, 202624d | Filing |
| DGilbert Ray Cisneros, Jr. | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Buy | Self | $1,001 - $15,000 | +8.6% | Nov 12, 2025 | Dec 15, 202533d | Filing |
| DJulie Johnson | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Partial | Joint | $1,001 - $15,000 | -16.9% | Nov 13, 2025 | Dec 11, 202528d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Dependent | $1,001 - $15,000 | +15.0% | Nov 3, 2025 | Dec 8, 202535d | FilingOCR |
| DGilbert Ray Cisneros, Jr. | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Partial | Self | $1,001 - $15,000 | -23.1% | Oct 9, 2025 | Nov 18, 202540d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Sell | Dependent | $1,001 - $15,000 | -29.4% | Sep 29, 2025 | Oct 3, 20254d | FilingOCR |
| DVal T. Hoyle | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Buy | Spouse | $1,001 - $15,000 | +25.1% | Oct 29, 2024 | Sep 12, 2025318d | Filing |
| DJulie Johnson | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Partial | Joint | $1,001 - $15,000 | -21.3% | Aug 14, 2025 | Sep 11, 202528d | Filing |
| RVirginia Foxx | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Self | $1,001 - $15,000 | -17.3% | Jun 24, 2025 | Jul 3, 20259d | Filing |
| RJefferson Shreve | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Self | $15,001 - $50,000 | -12.4% | May 12, 2025 | Jun 22, 202541d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY Cmn | Partial | Dependent | $1,001 - $15,000 | -4.8% | May 19, 2025 | Jun 10, 202522d | FilingOCR |
| RTommy Tuberville | BMY | Bristol-Myers Squibb Company | Sell | Self | $1,001 - $15,000 | -13.7% | Apr 15, 2025 | May 15, 202530d | Filing |
| DJulie Johnson | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Joint | $1,001 - $15,000 | -18.3% | Apr 1, 2025 | May 14, 202543d | Filing |
| DGreg Landsman | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Joint | $1,001 - $15,000 | +28.7% | Mar 27, 2025 | Apr 8, 202512d | Filing |
| DJulie Johnson | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Buy | Joint | $1,001 - $15,000 | -9.1% | Jan 15, 2025 | Feb 12, 202528d | Filing |
| RVirginia Foxx | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Buy | Self | $1,001 - $15,000 | -11.7% | Dec 6, 2024 | Jan 6, 202531d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Dependent | $1,001 - $15,000 | -13.5% | Nov 15, 2024 | Dec 5, 202420d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Dependent | $1,001 - $15,000 | -6.0% | Aug 5, 2024 | Sep 6, 202432d | FilingOCR |
| RJohn James | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Sell | Self | $1,001 - $15,000 | +7.8% | Jan 18, 2024 | Sep 2, 2024228d | Filing |
| RJohn James | BMY | Bristol-Myers Squibb Company Common Stock (BMY) | Buy | Self | $1,001 - $15,000 | -7.8% | Nov 10, 2023 | Sep 2, 2024297d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | BuyReview | Unknown | $1,001 - $15,000 | -5.6% | Jul 2, 2024 | Aug 7, 202436d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Spouse | $1,001 - $15,000 | -5.6% | Jul 1, 2024 | Aug 7, 202437d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Sell | Spouse | $15,001 - $50,000 | -16.0% | May 28, 2024 | Jun 5, 20248d | FilingOCR |
| RTommy Tuberville | BMY | Bristol-Myers Squibb Company Common Stock Option Type: Put Strike price: $50.00 Expires: 06/21/2024 | Buy | Joint | $1,001 - $15,000 | -3.3% | Apr 3, 2024 | May 15, 202442d | Filing |
| RTommy Tuberville | BMY | Bristol-Myers Squibb Company Common Stock | Sell | Joint | $1,001 - $15,000 | -3.3% | Apr 3, 2024 | May 15, 202442d | Filing |
| DRo Khanna | BMY | Bristol-Myers Squibb Co Com | Sell | Self | $1,001 - $15,000 | -1.9% | Apr 26, 2024 | May 6, 202410d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Dependent | $1,001 - $15,000 | +1.9% | Apr 26, 2024 | May 6, 202410d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Dependent | $15,001 - $50,000 | -18.4% | Mar 25, 2024 | Apr 5, 202411d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Spouse | $15,001 - $50,000 | -25.5% | Feb 13, 2024 | Mar 6, 202422d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Sell | Dependent | $1,001 - $15,000 | +25.5% | Feb 13, 2024 | Mar 6, 202422d | FilingOCR |
| RTommy Tuberville | BMY | Bristol-Myers Squibb Company Common Stock | Partial | Joint | $1,001 - $15,000 | +17.9% | Jan 3, 2024 | Feb 14, 202442d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | BuyReview | Unknown | $15,001 - $50,000 | -17.2% | Jan 10, 2024 | Feb 5, 202426d | FilingOCR |
| DRick Larsen | BMY | Bristol-Myers Squibb Company (BMY) | Sell | Self | $1,001 - $15,000 | +26.0% | Jan 9, 2024 | Jan 19, 202410d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Sell | Dependent | $1,001 - $15,000 | +35.6% | Dec 5, 2023 | Jan 4, 202430d | FilingOCR |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY | Sell | Spouse | $15,001 - $50,000 | +35.6% | Dec 4, 2023 | Jan 4, 202431d | FilingOCR |
| RTommy Tuberville | BMY | Bristol-Myers Squibb Company Option Type: Put Strike price: $50.00 Expires: 06/21/2024 | Sell | Joint | $1,001 - $15,000 | -32.1% | Nov 16, 2023 | Dec 15, 202329d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Dependent | $1,001 - $15,000 | -34.6% | Nov 3, 2023 | Dec 6, 202333d | FilingOCR |
| RTommy Tuberville | BMY | Bristol-Myers Squibb Company Common Stock | Buy | Joint | $1,001 - $15,000 | -38.6% | Oct 17, 2023 | Nov 16, 202330d | Filing |
| DGreg Stanton | BMY | Bristol-Myers Squibb Company (BMY) | Sell | Spouse | $1,001 - $15,000 | +43.7% | Oct 24, 2023 | Nov 9, 202316d | Filing |
| DGreg Stanton | BMY | Bristol-Myers Squibb Company (BMY) | Buy | Spouse | $1,001 - $15,000 | -43.7% | Sep 26, 2023 | Nov 9, 202344d | Filing |
| DRo Khanna | BMY | BRISTOL-MYERS SQUIBB COMPANY CMN | Buy | Spouse | $15,001 - $50,000 | -47.2% | Oct 10, 2023 | Nov 8, 202329d | FilingOCR |
Insider activity Filed
Insiders
28
Pharmaceutical Preparations
Open-market buys · 90d
0
$0 bought
Open-market sells · 90d
2
$437.2K sold
Net · 90d
-$437.2K
-$2.3M net over 12 months · last Nov 3, 2026
| Date | Insider | Kind | Security | Shares | Price | Value | Post-holdings | D/I | 10b5-1 | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2026filed Nov 4, 2026 | Adam LenkowskyEVP, Chief Commercial Officer | Exercise | Restricted Stock Unitsderiv. | −7,522 | $0.00 | — | 15,046 | D | — | 4 |
| Nov 3, 2026filed Nov 4, 2026 | Adam LenkowskyEVP, Chief Commercial Officer | Withholding | Common Stock, $0.10 par value | −3,848 | $61.71 | $237,460 | 23,380 | D | — | 4 |
| Nov 3, 2026filed Nov 4, 2026 | Adam LenkowskyEVP, Chief Commercial Officer | Exercise | Common Stock, $0.10 par value | 7,522 | $0.00 | $0 | 27,228 | D | — | 4 |
| Nov 1, 2026filed Nov 3, 2026 | Christopher S. BoernerChief Executive Officer | Exercise | Market Share Unitsderiv. | −2,964 | $0.00 | — | 2,966 | D | — | 4 |
| Nov 1, 2026filed Nov 3, 2026 | Christopher S. BoernerChief Executive Officer | Withholding | Common Stock, $0.10 par value | −1,724 | $62.48 | $107,716 | 23,097 | D | — | 4 |
| Nov 1, 2026filed Nov 3, 2026 | Christopher S. BoernerChief Executive Officer | Other | Common Stock, $0.10 par value | 406 | $0.00 | $0 | 24,821 | D | — | 4 |
| Nov 1, 2026filed Nov 3, 2026 | Christopher S. BoernerChief Executive Officer | Exercise | Common Stock, $0.10 par value | 2,964 | $0.00 | $0 | 24,415 | D | — | 4 |
| Nov 1, 2026filed Nov 3, 2026 | Karin ShanahanEVP, Chief Supply Chain & Ops | Exercise | Restricted Stock Unitsderiv. | −6,281 | $0.00 | — | 6,281 | D | — | 4 |
| Nov 1, 2026filed Nov 3, 2026 | Karin ShanahanEVP, Chief Supply Chain & Ops | Withholding | Common Stock, $0.10 par value | −3,213 | $62.48 | $200,748 | 28,956 | D | — | 4 |
| Nov 1, 2026filed Nov 3, 2026 | Karin ShanahanEVP, Chief Supply Chain & Ops | Exercise | Common Stock, $0.10 par value | 6,281 | $0.00 | $0 | 32,169 | D | — | 4 |
Shares, prices and post-transaction holdings are exactly as reported on SEC Form 4. Net figures count open-market buys minus open-market sales only (awards, exercises, withholding and gifts are excluded).
Unusual activity Estimated
- 43Committee overlapPublic Jun 11, 2026 · traded May 7, 2026
Rep. Mike Kelly's spouse sold $15,001–$50,000 of BMY; Rep. Mike Kelly sits on House Ways and Means
Details
- Committee
- House Committee on Ways and Means
- Leadership seat
- No
- Sector
- Healthcare
- Disclosed range
- $15,001 - $50,000
- Traded
- May 7, 2026
- Filed
- Jun 11, 2026
- Public from
- Jun 11, 2026
- Method version
- 2026-11-03
- 50Insider overlapPublic Jan 13, 2026 · traded Apr 28, 2025
Rep. Julia Letlow sold BMY 11 days before its President sold $4K
Details
- Politician
- Julia Letlow
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company Common Stock (BMY)
- Tx type
- sell
- Traded
- Apr 28, 2025
- Filed
- Jan 13, 2026
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 260
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- -11
- Opposite side
- No
- Public from
- Jan 13, 2026
- Method version
- 2026-11-03
- 43Hindsight movePublic Dec 16, 2025 · traded Nov 3, 2025
BMY rose 18% in the 30 trading days after Rep. Ro Khanna's dependent child's buy (hindsight)
Details
- Politician
- Ro Khanna
- Ticker
- BMY
- Asset
- BRISTOL-MYERS SQUIBB COMPANY CMN
- Tx type
- buy
- Traded
- Nov 3, 2025
- Filed
- Dec 8, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 35
- Owner type
- dependent
- Is whale
- No
- Entry date
- Nov 3, 2025
- Entry close
- 46.02
- Exit date
- Dec 16, 2025
- Exit close
- 54.23
- Forward return
- +17.8%
- Sign adjusted return
- +17.8%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- Dec 16, 2025
- Method version
- 2026-11-03
- 50Insider overlapPublic Jun 22, 2025 · traded May 12, 2025
Rep. Jefferson Shreve sold BMY 3 days after its President sold $4K
Details
- Politician
- Jefferson Shreve
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company Common Stock (BMY)
- Tx type
- sell
- Traded
- May 12, 2025
- Filed
- Jun 22, 2025
- Amount low
- $15,001
- Amount high
- $50,000
- Range midpoint (estimate)
- $32,501
- Disclosed range
- $15,001 - $50,000
- Reporting lag days
- 41
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- 3
- Opposite side
- No
- Public from
- Jun 22, 2025
- Method version
- 2026-11-03
- 50Insider overlapPublic Jun 10, 2025 · traded May 19, 2025
Rep. Ro Khanna's dependent child partially sold BMY 10 days after its President sold $4K
Details
- Politician
- Ro Khanna
- Ticker
- BMY
- Asset
- BRISTOL-MYERS SQUIBB COMPANY Cmn
- Tx type
- partial_sale
- Traded
- May 19, 2025
- Filed
- Jun 10, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 22
- Owner type
- dependent
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- 10
- Opposite side
- No
- Public from
- Jun 10, 2025
- Method version
- 2026-11-03
- 50Insider overlapPublic May 15, 2025 · traded Apr 15, 2025
Sen. Tommy Tuberville sold BMY 24 days before its President sold $4K
Details
- Politician
- Tommy Tuberville
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company
- Tx type
- sell
- Traded
- Apr 15, 2025
- Filed
- May 15, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 30
- Owner type
- self
- Is whale
- No
- Insider trade
- {"insider":{"slug":"benjamin-hickey","name":"Benjamin Hickey","title":"President, RayzeBio Org.","short_title":"President"},"company":"BRISTOL MYERS SQUIBB CO","ticker":"BMY","tx_kind":"open_market_sale","tx_date":"2025-05-09","shares":97.391,"price":38.01,"value":3701.83,"is_10b5_1":false,"filing_date":"2025-05-13"}
- Days between
- -24
- Opposite side
- No
- Public from
- May 15, 2025
- Method version
- 2026-11-03
- 51Hindsight movePublic May 14, 2025 · traded Apr 1, 2025
BMY fell 26% in the 30 trading days after Rep. Julie Johnson (joint account)'s sale (hindsight)
Details
- Politician
- Julie Johnson
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company Common Stock (BMY)
- Tx type
- sell
- Traded
- Apr 1, 2025
- Filed
- May 14, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 43
- Owner type
- joint
- Is whale
- No
- Entry date
- Apr 1, 2025
- Entry close
- 59.55
- Exit date
- May 14, 2025
- Exit close
- 44.12
- Forward return
- -25.9%
- Sign adjusted return
- +25.9%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- May 14, 2025
- Method version
- 2026-11-03
- 46Hindsight movePublic May 9, 2025 · traded Mar 27, 2025
BMY fell 21% in the 30 trading days after Rep. Greg Landsman (joint account)'s sale (hindsight)
Details
- Politician
- Greg Landsman
- Ticker
- BMY
- Asset
- Bristol-Myers Squibb Company Common Stock (BMY)
- Tx type
- sell
- Traded
- Mar 27, 2025
- Filed
- Apr 8, 2025
- Amount low
- $1,001
- Amount high
- $15,000
- Range midpoint (estimate)
- $8,001
- Disclosed range
- $1,001 - $15,000
- Reporting lag days
- 12
- Owner type
- joint
- Is whale
- No
- Entry date
- Mar 27, 2025
- Entry close
- 58.90
- Exit date
- May 9, 2025
- Exit close
- 46.45
- Forward return
- -21.1%
- Sign adjusted return
- +21.1%
- N trading days
- 30
- Hindsight
- Yes
- Measured from
- trade date
- Public from
- May 9, 2025
- Method version
- 2026-11-03
- 46Exec buyPublic Feb 21, 2025 · traded Feb 20, 2025
BMY CEO Christopher S. Boerner bought $110K on the open market
Details
- Insider
- Christopher S. Boerner
- Company
- BRISTOL MYERS SQUIBB CO
- Ticker
- BMY
- Tx kind
- open_market_buy
- Traded
- Feb 20, 2025
- Shares
- 2,000
- Price
- $55
- Value
- $110.1K
- Is 10b5 1
- No
- Filed
- Feb 21, 2025
- Public from
- Feb 21, 2025
- Method version
- 2026-11-03